tiprankstipranks
Trending News
More News >
MedWellAI (MWAI)
OTHER OTC:MWAI
US Market
Advertisement

MedWellAI (MWAI) AI Stock Analysis

Compare
66 Followers

Top Page

MWAI

MedWellAI

(OTC:MWAI)

Select Model
Select Model
Select Model
Neutral 50 (OpenAI - 4o)
Rating:50Neutral
Price Target:
$0.50
▼(-1.96% Downside)
The overall stock score of 50.1 is primarily influenced by the company's strong revenue growth, despite significant profitability and financial stability challenges. Technical indicators provide some optimism with bullish momentum, but the negative P/E ratio and lack of dividends weigh heavily on valuation.

MedWellAI (MWAI) vs. SPDR S&P 500 ETF (SPY)

MedWellAI Business Overview & Revenue Model

Company DescriptionIntegrated Ventures, Inc. engages in the digital currency mining operations. The company manufactures equipment; and sells mining rigs, as well as develops blockchain software. As of June 30, 2021, it owned approximately 914 miners that mine bitcoin, litecoin, Zcash, and ethereum. The company is based in Huntingdon Valley, Pennsylvania.
How the Company Makes MoneyMedWellAI generates revenue through a combination of product sales, subscription-based services, and strategic partnerships. The company licenses its AI-driven software solutions to hospitals, clinics, and other healthcare providers, offering both one-time licensing fees and ongoing subscription models for continuous access and updates. Additionally, MWAI collaborates with pharmaceutical companies and research institutions to develop specialized AI applications, often entering into revenue-sharing agreements or receiving funding for joint projects. The company also benefits from partnerships with healthcare technology integrators who help deploy its solutions across various healthcare settings, expanding its market reach.

MedWellAI Financial Statement Overview

Summary
Income Statement
25
Negative
Balance Sheet
15
Very Negative
Cash Flow
20
Very Negative
Breakdown
Income Statement
Total Revenue
Gross Profit
EBITDA
Net Income
Balance Sheet
Total Assets
Cash, Cash Equivalents and Short-Term Investments
Total Debt
Total Liabilities
Stockholders Equity
Cash Flow
Free Cash Flow
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

MedWellAI Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.51
Price Trends
50DMA
0.57
Negative
100DMA
0.47
Positive
200DMA
0.52
Negative
Market Momentum
MACD
-0.01
Negative
RSI
40.44
Neutral
STOCH
91.88
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MWAI, the sentiment is Negative. The current price of 0.51 is below the 20-day moving average (MA) of 0.51, below the 50-day MA of 0.57, and below the 200-day MA of 0.52, indicating a bearish trend. The MACD of -0.01 indicates Negative momentum. The RSI at 40.44 is Neutral, neither overbought nor oversold. The STOCH value of 91.88 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MWAI.

MedWellAI Risk Analysis

MedWellAI disclosed 12 risk factors in its most recent earnings report. MedWellAI reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

MedWellAI Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
50
Neutral
$3.03M-795.90%-75.76%91.24%
41
Neutral
4.38M-0.02-96.03%95.03%
40
Underperform
3.61M-0.02855.46%-19.53%92.37%
39
Underperform
427.40M-0.60-63.75%4095.10%93.91%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MWAI
MedWellAI
0.51
-0.48
-48.48%
FRGT
Freight Technologies
1.30
-7.30
-84.88%
TONX
TON Strategy Company
6.97
-3.19
-31.40%
AMST
Amesite
3.14
0.54
20.77%
AUUD
Auddia
2.16
-9.45
-81.40%
TGL
Treasure Global, Inc.
1.08
-62.92
-98.31%

MedWellAI Corporate Events

Delistings and Listing Changes
MedWellAI Announces Stock Symbol Change to MWAI
Neutral
Jun 24, 2025

On May 30, 2025, Integrated Ventures, Inc. received confirmation of its name change to MedwellAI, Inc. from the Secretary of State of Nevada. On June 17, 2025, FINRA announced that the name and stock symbol change to ‘MWAI’ would take effect on June 18, 2025. These changes do not affect shareholders’ equity interests or voting rights.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 01, 2025